Skylands Capital, LLC Bristol Myers Squibb CO Transaction History

Skylands Capital, LLC

$684 Million
Q3 2024

A detailed history of Skylands Capital, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Skylands Capital, LLC holds 181,075 shares of BMY stock, worth $10.5 Million. This represents 1.37% of its overall portfolio holdings.

Number of Shares

181,075

Previous 220,800 17.99%

Holding current value

$10.5 Million

Previous $9.17 Million 2.19%

% of portfolio

1.37%

Previous 1.39%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 01, 2024	SELL	$39.66 - $51.75 $1.58 Million - $2.06 Million	-39,725 Reduced 17.99%	181,075 $9.37 Million
Q2 2024 Jul 26, 2024	BUY	$40.25 - $52.99 $1.29 Million - $1.7 Million	32,150 Added 17.04%	220,800 $9.17 Million
Q1 2024 May 03, 2024	BUY	$47.98 - $54.4 $461,807 - $523,600	9,625 Added 5.38%	188,650 $10.2 Million
Q4 2023 Feb 05, 2024	SELL	$48.48 - $57.85 $866,580 - $1.03 Million	-17,875 Reduced 9.08%	179,025 $9.19 Million
Q3 2023 Oct 27, 2023	BUY	$57.89 - $64.73 $859,666 - $961,240	14,850 Added 8.16%	196,900 $11.4 Million
Q2 2023 Aug 03, 2023	SELL	$63.71 - $70.74 $316,957 - $351,931	-4,975 Reduced 2.66%	182,050 $11.6 Million
Q1 2023 May 04, 2023	BUY	$65.71 - $74.53 $4.72 Million - $5.35 Million	71,800 Added 62.31%	187,025 $13 Million
Q4 2022 Feb 09, 2023	SELL	$68.48 - $81.09 $772,112 - $914,289	-11,275 Reduced 8.91%	115,225 $8.29 Million
Q3 2022 Nov 01, 2022	SELL	$0.13 - $76.84 $572 - $338,096	-4,400 Reduced 3.36%	126,500 $8.99 Million
Q2 2022 Jul 28, 2022	SELL	$72.62 - $79.98 $2.66 Million - $2.93 Million	-36,620 Reduced 21.86%	130,900 $10.1 Million
Q1 2022 May 05, 2022	SELL	$61.48 - $73.72 $1.97 Million - $2.36 Million	-32,025 Reduced 16.05%	167,520 $12.2 Million
Q4 2021 Feb 08, 2022	BUY	$53.63 - $62.52 $902,324 - $1.05 Million	16,825 Added 9.21%	199,545 $12.4 Million
Q3 2021 Nov 02, 2021	SELL	$59.17 - $69.31 $1.15 Million - $1.35 Million	-19,500 Reduced 9.64%	182,720 $10.8 Million
Q2 2021 Aug 02, 2021	SELL	$61.91 - $67.42 $705,774 - $768,588	-11,400 Reduced 5.34%	202,220 $13.4 Million
Q1 2021 May 04, 2021	BUY	$59.34 - $66.74 $1.41 Million - $1.59 Million	23,810 Added 12.54%	213,620 $13.5 Million
Q4 2020 Feb 09, 2021	BUY	$57.74 - $65.43 $1.71 Million - $1.93 Million	29,550 Added 18.44%	189,810 $11.8 Million
Q3 2020 Oct 27, 2020	BUY	$57.43 - $63.64 $849,964 - $941,872	14,800 Added 10.17%	160,260 $9.59 Million
Q2 2020 Jul 29, 2020	BUY	$54.82 - $64.09 $5.67 Million - $6.63 Million	103,470 Added 246.42%	145,460 $8.55 Million
Q1 2020 Apr 27, 2020	SELL	$46.4 - $67.43 $11,600 - $16,857	-250 Reduced 0.59%	41,990 $2.34 Million
Q4 2019 Feb 11, 2020	BUY	$49.21 - $64.19 $2.08 Million - $2.71 Million	42,240 New	42,240 $2.69 Million

Others Institutions Holding BMY

# of Institutions

2,532

Shares Held

1.47B

Call Options Held

31.6M

Put Options Held

35M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $123B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Skylands Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Skylands Capital, LLC with notifications on news.

Account

Skylands Capital, LLC Bristol Myers Squibb CO Transaction History